Page last updated: 2024-09-03

ezogabine and Convulsive Generalized Seizure Disorder

ezogabine has been researched along with Convulsive Generalized Seizure Disorder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bleakley, LE; McKenzie, CE; Reid, CA1
Kelly, M; Knight, D; Mahida, S; Olson, HE; Poduri, A1
Biton, V; DeRossett, S; Nohria, V; Partiot, A; Porter, RJ; Rosenfeld, WE; Sachdeo, R; Tompson, D1

Trials

1 trial(s) available for ezogabine and Convulsive Generalized Seizure Disorder

ArticleYear
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
    International journal of clinical pharmacology and therapeutics, 2014, Volume: 52, Issue:6

    Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Phenylenediamines; Research Design; Risk Assessment; Time Factors; Treatment Outcome; United States; Young Adult

2014

Other Studies

2 other study(ies) available for ezogabine and Convulsive Generalized Seizure Disorder

ArticleYear
Efficacy of antiseizure medication in a mouse model of HCN1 developmental and epileptic encephalopathy.
    Epilepsia, 2023, Volume: 64, Issue:1

    Topics: Animals; Anticonvulsants; Epilepsy; Epilepsy, Generalized; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Lamotrigine; Mice; Potassium Channels; Seizures; Valproic Acid

2023
Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy.
    Epilepsia, 2023, Volume: 64, Issue:7

    Topics: Child, Preschool; Epilepsy; Epilepsy, Generalized; Humans; Infant; KCNQ2 Potassium Channel; Mutation; Retrospective Studies; Seizures

2023